• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKM:CN

29.3600 CAD 1.5100 5.42%

As of 14:01:48 ET on 10/02/2014.

Snapshot for Tekmira Pharmaceuticals Corp (TKM)

Open: 27.8300 Day's Range: 25.7600 - 29.9600 Volume: 490,118
Previous Close: 27.8500 52wk Range: 7.1600 - 34.6600 1-Yr Rtn: +296.22%

Stock Chart for TKM

No chart data available.
  • TKM:CN 29.3600
  • 1D
  • 1M
  • 1Y
27.8500
Interactive TKM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -1.7163
Est. EPS (USD) (12/2014) -1.6670
Est. PEG Ratio -
Market Cap (M CAD) 642.30
Shares Outstanding (M) 22.08
30 Day Average Volume 363,244
Price/Book (mrq) 5.5095
Price/Sale (ttm) 28.4611
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TKM

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Mark J MurrayPresident/CEOBruce CousinsExec VP:Finance/CFO
Ian MaclachlanExec VP/Chief Technical OfficerMichael J AbramsExec VP/Chief Discovery Officer
More Company Profile & Key Executives for TKM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil